Novel Aggregative Adherence Fimbria Variant of Enteroaggregative Escherichia coli by Jønsson, Rie et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 21, 2017
Novel Aggregative Adherence Fimbria Variant of Enteroaggregative Escherichia coli
Jønsson, Rie; Struve, Carsten ; Boisen, Nadia; Mateiu, Ramona Valentina; Santiago, Araceli E.; Jenssen,
Håvard; Nataro, James P.; Krogfelt, Karen A.
Published in:
Infection and Immunity
Link to article, DOI:
10.1128/IAI.02820-14
Publication date:
2015
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Jønsson, R., Struve, C., Boisen, N., Mateiu, R. V., Santiago, A. E., Jenssen, H., ... Krogfelt, K. A. (2015). Novel
Aggregative Adherence Fimbria Variant of Enteroaggregative Escherichia coli. Infection and Immunity, 83(4),
1396-1405. DOI: 10.1128/IAI.02820-14
Novel Aggregative Adherence Fimbria Variant of Enteroaggregative
Escherichia coli
Rie Jønsson,a,b Carsten Struve,a Nadia Boisen,a Ramona Valentina Mateiu,c Araceli E. Santiago,d Håvard Jenssen,b James P. Nataro,d
Karen A. Krogfelta
Department of Microbiology and Infection Control, Statens Serum Institut, Copenhagen, Denmarka; Department of Science, Systems and Models, Roskilde University,
Roskilde, Denmarkb; Center for Electron Nanoscopy, Technical University of Denmark, Kgs Lyngby, Denmarkc; Department of Pediatrics, University of Virginia School of
Medicine, University of Virginia, Charlottesville, Virginia, USAd
Enteroaggregative Escherichia coli (EAEC) organisms belong to a diarrheagenic pathotype known to cause diarrhea and can be
characterized by distinct aggregative adherence (AA) in a stacked-brick pattern to cultured epithelial cells. In this study, we in-
vestigated 118 EAEC strains isolated from the stools of Danish adults with traveler’s diarrhea. We evaluated the presence of the
aggregative adherence fimbriae (AAFs) by a multiplex PCR, targeting the four known major subunit variants as well as their
usher-encoding genes. Almost one-half (49/118) of the clinical isolates did not possess any known AAF major fimbrial subunit,
despite the presence of other AggR-related loci. Further investigation revealed the presence of an AAF-related gene encoding a
yet-uncharacterized adhesin, termed agg5A. The sequence of the agg5DCBA gene cluster shared fimbrial accessory genes (usher,
chaperone, and minor pilin subunit genes) with AAF/III, as well as the signal peptide present in the beginning of the agg3A gene.
The complete agg5DCBA gene cluster from a clinical isolate, EAEC strain C338-14, with the typical stacked-brick binding pat-
tern was cloned, and deletion of the cluster was performed. Transformation to a nonadherent E. coli HB101 and complementa-
tion of the nonadherent C338-14 mutant with the complete gene cluster restored the AA adhesion. Overall, we found the agg5A
gene in 12% of the 118 strains isolated from Denmark, suggesting that this novel adhesin represents an important variant.
During the past decades, enteroaggregative Escherichia coli(EAEC) has emerged as an important pathogen, causing di-
arrhea in adults and children in both industrialized and nonindus-
trialized countries (1–5). Moreover, EAEC has also been linked to
diarrheal outbreaks (6, 7) including a recent outbreak of food-
borne hemorrhagic colitis in Germany affecting more than 4,000
individuals and resulting in a high case fatality rate (8, 9). Addi-
tionally, an EAEC urinary tract infection-related outbreak was
reported in Denmark (10). Nevertheless, despite EAEC implica-
tions in several clinical scenarios, the molecular epidemiology of
this pathogen remains unclear. This is mostly due to the hetero-
geneity of strains, and even though several virulence genes have
been identified in EAEC, none have shown to be present in all
strains (11–14), making the recognition of truly virulent strains
difficult.
Several reports suggest that the key step in EAEC pathogenesis
is the ability of the pathogen to adhere to and colonize the intes-
tinal tract, which in EAEC prototype strains is facilitated by aggre-
gative adherence fimbriae (AAF), followed by heavy biofilm for-
mation (15–18). Four variants of the AAF major structural
subunit have been described so far: AggA (AAF/I), AafA (AAF/II),
Agg3A (AAF/III), and Agg4A (AAF/IV), all regulated by the tran-
scriptional activator AggR, situated on the EAEC virulence plas-
mid pAA (19–23). AAFs are distantly related to the Dr family of
adhesins, whose biogenesis requires a dedicated periplasmic chap-
erone, an outer membrane usher protein, and two surface-ex-
pressed subunits (a major subunit and a putative cap subunit) (22,
24). AAFs and Dr adhesins display a high level of conservation of
the usher and chaperone genes and a sequence divergence of the
fimbrial subunit genes (24). Previous studies have shown that ap-
proximately one-half of clinical EAEC isolates do not express any
of the four known AAF variants, despite the presence of the pAA
plasmid and/or other EAEC-specific genes (11, 12). In this study,
we investigated 118 Danish EAEC strains for the presence of AAF
genes. Sixty-nine strains were found positive for one of the four
known major pilin subunits (58%), whereas the gene for the most
frequent AAF variant found was aggA (21%), followed by agg4A
(19%), aafA (9%), and agg3A (9%). Forty-one percent of the
strains in the collection were negative for a known major pilin
subunit, although 80% of these strains harbored the closely related
usher gene for AAF/III and AAF/IV variants. Taken together, these
findings strongly suggest the presence of uncharacterized adhesins
in these EAEC strains. Accordingly, here we report the character-
ization of a novel adhesin variant (AAF/V) in EAEC related to the
Afa/Dr/AAF family. AAF/V was found in 12% of the clinical iso-
lates, suggesting that this adhesin is prevalent among EAEC
strains.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The bacterial strains
and plasmids used in this study are listed in Table 1. The 118 EAEC strains
were isolated from consecutive fecal samples submitted for routine anal-
ysis from patients suffering from traveler’s diarrhea illness in Denmark
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during 2011 to 2013. An E. coli strain, C338-14, which was isolated from a
69-year-old woman returning from Tanzania, showed high AA binding to
cells and was selected for further characterization. Prototype strains
JM221, 042, 55989, and C1010-00, each expressing one of the four AAFs,
were used in this study (21, 22, 25, 26). E. coli strain 226 was isolated from
a 3-year-old female with hemolytic-uremic syndrome (HUS) by the Lab-
oratory of Gastrointestinal Pathogens at the Health Protection Agency in
Colindale, United Kingdom, in February 2012; it harbored the Shiga toxin
(Stx) type 2c-encoding gene stx2c as well as aggR and AggR-regulated
genes (27).
Stock cultures were frozen at 80°C in Statens Serum Institut (SSI)
Luria broth (LB) containing 10% (vol/vol) glycerol. All strains were
grown at 37°C. Chloramphenicol (30g ml1), apramycin (30g ml1),
ampicillin (100 g ml1), and kanamycin (50 g ml1) were added ap-
propriately.
Characterization of EAEC strains by PCR. All primers and their cor-
responding product sizes are listed in Table 2. DNA templates were ob-
tained by using the DNeasy blood and tissue kit (QIAgen, Inc., Valencia,
CA) according to the manufacturer’s instructions. Detection of the four
AAF-encoding genes, aggA, aafA, agg3A, and agg4A, was performed as
previously described (12). Singleplex PCR amplifications were performed
by using the Maxima Hot Start PCR master mix (2; Thermo Scientific,
Inc., MA, USA) according to the manufacturer’s instructions. The single-
plex PCR cycles comprised (i) denaturation for 2 min at 94°C, (ii) dena-
turation for 30 s, (iii) annealing for 30 s at the primer-specific tempera-
ture, and (iv) extension for 1.5 min for 55°C with 35 cycles of steps 2 to 4.
The final extension was for 10 min at 72°C.
Cloning of the AAF/V gene cluster. The AAF/III and the two AAF/V
gene clusters were amplified from E. coli strains 55989, C338-14, and 226,
respectively, using the Expand Long Template PCR system (Roche Ap-
plied Science, Penzberg, Germany). XbaI and SalI restriction sites were
introduced at the 5= ends of the PCR primers (Table 2). The PCR products
were digested with the respective restriction enzymes and ligated into the
corresponding sites of pACYC184. The constructs were verified by Sanger
sequencing (Macrogen, Seoul, South Korea). The plasmid was then trans-
formed into the nonfimbriated laboratory E. coli strain HB101 (28).
Construction of an isogenic agg5DCBA and aggR deletion mutant.
The AAF/V cluster (agg5DCBA) and the aggR gene in strain C338-14 were
both deleted by allelic exchange with a PCR-synthesized cassette encoding
kanamycin resistance flanked by regions homologous to the regions up-
and downstream of the AAF/V cluster and the aggR gene, respectively. All
primers used are listed in Table 2. The aggR cassette was generated by PCR
amplification from a previously constructed JM221aggR mutant strain
using primers UpaggR_F and DwaggR_R (29).
The agg5DCBA cassette was generated by a three-step PCR procedure,
previously described by Struve et al. (30). At the first step, the kanamycin
resistance-encoding gene (kan) was generated from pKD4 by use of prim-
ers Kn1 and Kn2 (31). Second, from C338-14 chromosomal DNA, a
358-bp region and a 343-bp region flanking the agg5 gene cluster were
PCR amplified by use of primers Upagg5D_F and Upagg5D_R and prim-
ers Dwagg5A_F and Dwagg5A_R, respectively. At their 5= ends, the prim-
ers Upagg5D_R and Dwagg5A_F contained 20-bp regions homologous to
the extremities of the kan gene. In the third step, the flanking regions were
added on each side of the kan gene by mixing 100 ng of each fragment,
followed by PCR amplification using primers Upagg5D_F and
Dwagg5A_R. The purified PCR products were transformed into strain
C338-14 harboring the thermosensitive plasmid pKOBEGApra, which
encodes the lambda Red recombinase (32). Both the agg5A and aggR
mutants were selected on LB agar plates containing kanamycin and incu-
bated overnight at 37°C, and the loss of the pKOBEGApra plasmid was
verified by the inability of the mutant to grow on LB agar plates containing
apramycin. Successful allelic exchange was verified by PCR analysis using
the primers listed in Table 2.
RNA extraction and RT-PCR. Overnight cultures of C338-14, C338-
14aggR, and C338-14agg5ABCDwere diluted 1:100 in 20 ml of Dulbecco’s
modified Eagle medium (DMEM) (1%) supplemented with 0.45% glu-
cose (DMEM-HG). The strains were incubated with shaking at 37°C until
an optical density at 600 nm (OD600) of 0.8 was reached. RNA was ex-
tracted using the RNase Plus minikit with the addition of an optional
on-column digestion in order to remove contaminating DNA using the
RNase-Free DNase Set (Qiagen, Inc., Valencia, CA). RNA was quantified
using a Qubit RNA BR assay (Life Technologies, Carlsbad, CA, USA).
cDNA was synthesized from 1 g of RNA by using random hexamer
primers and the Thermoscript reverse transcriptase (RT) enzyme (Invit-
rogen, Carlsbad, CA, USA) for 10 min at 25°C, 1 h at 50°C, and 5 min at
85°C. PCR was performed to standard procedures with Platinum Taq
TABLE 1 Strains and plasmids used in this study
Strain or plasmid Descriptiona
Reference or
source
Strains
226 Wild-type EAEC expressing AAF/V 27
C338-14 Wild-type EAEC expressing AAF/V This study
C338-14agg5ABCD C338-14 in which a kanamycin cassette was inserted into the agg5DCBA gene cluster; Kanr This study
C338-14aggR C338-14 in which a kanamycin cassette was inserted into the aggR gene; Kanr This study
JM221 Wild-type EAEC expressing AAF/I 23
042 Wild-type EAEC expressing AAF/II 25
55989 Wild-type EAEC expressing AAF/III 21
C1010-00 Wild-type EAEC expressing AAF/IV 22
HB101 Nonfimbriated, noncapsulated E. coli K-12 laboratory strain 28
HB101(pDKAAF5) HB101 transformed with pDKAAF5; Cmr This study
HB101(pUKAAF5) HB101 transformed with pUKAAF5; Cmr This study
HB101(pAAF/3) HB101 transformed with pAAF/3; Cmr This study
MG1655 Commensal E. coli K-12 strain 38
Plasmids
pDKAAF5 pACYC184, low-copy-no. vector containing agg5DCBA from strain C338-14; Cmr This study
pUKAAF5 pACYC184, low-copy-no. vector containing agg5DCBA from strain 226; Cmr This study
pAAF/3 pACYC184, low-copy-no. vector containing agg3DCBA from strain 55989; Cmr This study
pKOBEGApra Thermosensitive plasmid encoding the lambda red recombinase; Aprar 32
pBADaggR pBAD, expression plasmid encoding the transcriptional activator aggR; Ampr 49
a Kan, kanamycin; Cm, chloramphenicol; Apra, apramycin; Amp, ampicillin.
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DNA polymerase (Invitrogen, Carlsbad, CA, USA). The constitutively
expressed housekeeping gene rpoA was used as a control (33). As negative
controls, all samples were tested without addition of reverse transcriptase.
HEp-2 cell adherence assays (stacked-brick AA pattern). Cells from
the human larynx cancer-derived epithelial cell line HEp-2 (ATCC CCL-
23) were maintained in RPMI 1640 medium (Invitrogen) containing 10%
fetal bovine serum (FBS) according to the manufacturer’s instructions.
For detection of the aggregative adherence pattern (19), cells were
grown overnight to 50% confluence in Dulbecco’s Eagle’s minimal essen-
tial medium and 10% fetal calf serum on Nunc Lab-Tek Chamber slides at
37°C. Overnight cultures of EAEC were diluted 100-fold, subcultured in
DMEM for 4 h, and washed, and then the cells were infected with 10l of
bacterial suspension (1 108 CFU) for 3 h at 37°C. After incubation, the
cells were washed with phosphate-buffered saline (PBS), fixed with 10%
(vol/vol) formalin for 10 min, and stained with 0.1% crystal violet (Sigma
Chemical Co., St. Louis, MO) for 5 min, followed by washing of the slides.
The cells were visualized under light microscopy (Olympus BX61).
For the HEp-2 cell adherence assay, 25l of bacterial suspension (2
106 bacteria) was added to confluent monolayers in a 24-well plate (Nunc
Intermed) and incubated at 37°C in 5% CO2 for 3 h. Cells were washed 3
times with PBS and incubated with 500 l of 0.5% Triton X-100 (Sigma
Chemical Co., St. Louis, MO) in PBS for 30 min at room temperature. The
medium was serially diluted and plated on LB agar containing antibiotics
when appropriate. To calculate the percentage recovery of adherent bac-
teria, bacteria were enumerated by colony counts before and after the
infection period. The data shown are numbers of cell-associated bacteria
relative to the numbers of bacteria recovered.
Biofilm assay. The EAEC biofilm assay was performed as previously
described by Sheikh et al. (17) and modified as described in reference 29.
HA of red blood cells by whole bacteria. Hemagglutination (HA) has
been shown to correlate with AAF adhesin expression by EAEC strains
(19, 20). Fresh erythrocytes were obtained from a human volunteer (A
rhesus positive), and the HA assay was performed as previously described
(34).
SEM. Strains were grown in LB overnight with shaking at 37°C. The
next day, strains were diluted 1:100 in 5 ml DMEM-high glucose and
incubated with shaking to reach an OD600 of 0.8. A 1-ml sample was
washed, fixed in 3% glutaraldehyde in PBS (pH 7.3) for 16 h, and washed
3 times in distilled water, followed by staining with 1% OsO4 at 4°C for 16
h. The next day, the sample was dehydrated in several steps of ethanol,
followed by steps of acetone. Next, the samples were pipetted onto a filter
disc with pore sizes of 1 to 1.6 m and further dried in a CPD300 Leica.
After the critical point drying (CPD) step, the filter discs with the samples
were coated with platinum in a Cressington 208 HR High Resolution
Sputter Coater for 4 s at 80 mA, attached to an aluminum stub with a
double-sided C tape, and imaged in an FEI Helios Dual Beam scanning
electron microscope (SEM). The images were recorded with the Everhart
Thornely detector at 2 keV, spot 2.5, with 20-m aperture.
Nucleotide sequence and phylogenetic analyses. BLAST searches and
comparisons were conducted using the databases of the National Center
TABLE 2 Primers used in this study
Use Primer Sequence (5=–3=)
Reference or
source
AAF multiplex AGGA TCTATCTRGGGGGGCTAACGCT 12
ACCTGTTCCCCATAACCAGACC
AAFA CTACTTTATTATCAAGTGGAGCCGCTA
GGAGAGGCCAGAGTGAATCCTG
AAFC ACAGCCTGCGGTCAAAAGC
GCTTACGGGTACGAGTTTTACGG
AGG3A CCAGTTATTACAGGGTAACAAGGGAA
TTGGTCTGGAATAACAACTTGAACG
AGG3/4C TTCTCAGTTAACTGGACACGCAAT
TTAATTGGTTACGCAATCGCAAT
TCTGACCAAATGTTATACCTTCAYTATG
AGG4A TGAGTTGTGGGGCTAYCTGGA
CACCATAAGCCGCCAAATAAGC
agg5A detection primer AGG5A CATGTTCATTATCTATTAGTTCGCCTCCACCGTACGTCGTCATTA This study
Cloning primers AAF3/5_XBA_F GCGCGCTCTAGAAGCGTGGGCAGAGTCAGATTG This study
AAF5_SAL_R GCGCGCGTCGACTTAATTTAAGCTGAAGAATCCAGTC
AAF3_SAL_R GCGCGCGTCGACTTATGGTAAAACCATAACACCATGGG
Three-step knockout of
agg5DCBA
UPAGG5D_F CGTCAATACGGTGCTCTA
UPAGG5D_R GAAGCAGCTCCAGCCTACACGCTGGTGTTTTTTGGTCT This study
DWAGG5A_F GGACCATGGCTAATTCCCATCAGATGCTAAAGATGGAAAGCT
DWAGG5A_R TTCGTTAGCCAGAGCCTG
KN1 CAGTCATAGCCGAATAGCCT 30
KN2 CGGTGCCCTGAATGAACTGC
aggR knockout construction UPAGGR_F TCAAGAATTGTTTTGGTGTTATGC 28
DWAGGR_R AAAACAAAACATCGAAAAAGAGA
rpoA for RT-PCR RPOA_F TTGATATCGAGCAAGTGAGTTCG 31
RPOA_R GCATCGATGAGAGCAGAATACG
RT-PCR primer for agg5A AGG5A_100BP_F AGATGGAAAGCTTGTCATG This study
AGG5A_100BP_R GTGGTTACGGATATTATC
Jønsson et al.
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for Biotechnology Information (http://www.ncbi.nlm.nih.gov/BLAST/).
The sequences of Agg3A and Agg5A were analyzed using Needle (http:
//www.ebi.ac.uk/Tools/psa/emboss_needle/) at default settings. The se-
quences of Agg5A variants were analyzed using ClustalW (http://www.ebi
.ac.uk/Tools/msa/clustalw2/) at default settings. The putative signal
sequences were predicted by the SignalP algorithm (http://www.cbs.dtu
.dk/services/SignalP/).
Average pairwise nucleotide diversity () and the rates of synonymous
(dS) and nonsynonymous (dN) mutations between and within the clades
were calculated using the MEGA4 program (35). The analysis of sta-
tistical significance was performed using a Z-test with the  and dN/dS
values (36).
Statistical analyses. Student’s t test was used for statistical evaluation,
and P values of0.05 were considered statistically significant. Statistical
analyses and graphs were performed using GraphPad Prism v6.00
(GraphPad Software, San Diego, CA).
Nucleotide sequence accession number. The sequence of the agg5A
gene from strain C338-14 was deposited in GenBank under accession
number KP202151.
RESULTS
AAF characterization of Danish EAEC isolates. The 118 EAEC
strains used in this study were isolated from adult travelers with
diarrhea. The isolates were classified as EAEC when positive by
PCR for at least one of the following genes; aggR, aaiC, and/or
aatA. To determine the presence of the four previously described
AAFs among the isolates, a multiplex PCR was employed (12).
The results are listed in Table 3. Sixty-nine strains were found to
be positive for one of the four known major pilin subunits (58%).
The most frequent AAF pilin-encoding gene found was aggA
(AAF/I), found in 25 strains (21%), followed by agg4A (AAF/IV),
found in 22 strains (19%), aafA (AAF/II), found in 11 strains
(9%), and agg3A (AAF/III), found in 11 strains (9%). Forty-nine
(42%) of the strains in the collection were negative for a major
pilin subunit, although 39 (80%) of these harbored the closely
related usher genes for AAF/III and AAF/IV variants (agg3C and
agg4C). Thus, 10 (8.4%) of the 118 EAEC strains were negative for
any known aaf fimbrial gene and accessory genes. Therefore, we
hypothesized that these isolates harbored either distant homo-
logues of known AAF alleles or novel AAF pilins.
Adherence properties of the AAF-negative strains. EAEC can
be distinguished from other diarrheagenic E. coli by the formation
of an aggregative “stacked-brick” pattern of adherence (AA) by
AAF-mediated adhesion to HEp-2 cells (19). To investigate the
adherence properties of the 49 isolates negative for a known AAF
pilin subunit, we tested their ability to exhibit the aggregative or
stacked-brick pattern on HEp-2 cells. We found that among the 49
strains, 32 exhibited the stacked-brick pattern. The 17 strains that
did not exhibit the stacked-brick pattern were not characterized
further. The AA pattern of the 32 strains varied, ranging from the
typical honeycomb formation as exhibited by the EAEC prototype
strain 042 to other AA types (37) (data not shown).
As AAF expression has been shown to promote biofilm forma-
tion to abiotic surfaces (17), the isolates were also screened for
their ability to form biofilm in microtiter plates. The majority of
the isolates were found to produce significantly more biofilm than
the commensal E. coli strain MG1655 (38) (data not shown), in-
dicating expression of AAFs or other biofilm-promoting factors.
Identification of the agg5A gene. Further analysis of the AAF-
negative strains revealed that 25 of the 32 isolates exhibiting the
stacked-brick pattern were positive for the agg3C gene encoding
the usher protein of AFF/III. In the prototype AAF/III strain
55989, the aggR gene is located downstream of agg3C, and the
region interspacing the two genes includes agg3A, the gene encod-
ing the major pilin subunit of AAF/III (21). Therefore, in an effort
to reveal unknown AAF-related sequences, we performed PCR
with a forward primer targeting agg3C and a reverse primer tar-
geting aggR in a selected clinical isolate exhibiting high adhesion,
C338-14. Also, this isolate harbors aggR, aatA, and dispersin
genes, as well as the chromosomal gene aaiC, suggesting that it
carries the complete pAA virulence plasmid as well as the AAI
island (39). The PCR-amplified region between aggR and agg3C
from C338-14 was sequenced and was found to encode an unchar-
acterized AAF, termed here AAF/V. The whole AAF/V cluster was
subsequently obtained by PCR using primers located in the start of
agg3D and agg5A and sequenced.
Interestingly, upstream of the agg5A gene encoding the major
fimbrial subunit of AAF/V, three open reading frames (ORFs)
identical to the accessory genes (agg3D, agg3C, agg3B) of AAF/III
from prototype EAEC strain 55989 were identified (Fig. 1). Both
agg3A from strain 55989 and agg5A from C338-14 were located
174 bp downstream of agg3B. Alignment of the two major fimbria
subunits, agg3A and agg5A, revealed that the first 65 bp were 100%
identical whereas the following 451 bp of the sequences differed
(Fig. 1). Alignment of the two proteins (including the signal pep-
tides) showed that they shared 32.2% identity. Further analysis
revealed that the 65 bp shared were the signal peptide.
Comparison of the agg5A variants. BLAST analysis of the
agg5A gene from C338-14 revealed four other agg5A sequences;
three previously submitted to NCBI (accession numbers
AB513347, AB571097, and AB571098) and one agg5A sequence
found in a Shiga toxin (Stx) type 2c-producing EAEC strain
termed 226 (NCBI Short Read Archive accession number
SRA055981) (27). Translation of the five nucleotide sequences
showed that several of the unconserved regions had both silent
point mutations and altered amino acid composition among the
sequences. Alignment of the sequences (Fig. 2) revealed several
variable regions with percentage identity ranging from 83% to
100% among the isolates, except for the accessory genes and signal
sequence, which showed full conservation.
To test if the amino acid changes in the variants are the results of
adaptive mutations/selection, we calculated the ratio of nonsynony-
mous mutations (dN) to synonymous mutations (dS). This showed
that the rate of nonsynonymous mutations (dN) at 0.070 was signif-
icantly higher than the rate of synonymous mutations (dS) at 0.009
TABLE 3 Prevalence of agg5A in clinical strains
AAF pilin-encoding
gene (AAF type)
% Prevalence (no.) of strains carrying agg5A in
clinical strains from:
Danish strain
collection Mali strain collection (12)
Cases
(n 118)
Controls
(n 61)
Cases
(n 60)
Total
(n 121)
aggA (AAF/I) 21.1 (25) 18 (11) 35 (21) 26.4 (32)
aafA (AAF/II) 9.32 (11) 4.9 (3) 5 (3) 5 (6)
agg3A (AAF/III) 9.32 (11) 1.6 (1) 8.3 (5) 5 (6)
agg4A (AAF/IV) 18.6 (22) 8.2 (5) 1.6 (1) 5 (6)
agg5A (AAF/V) 11.8 (14) 14.75 (9) 13.3 (8) 14 (17)
None 29.6 (35)a 52.45 (32) 36.6 (22) 44.6 (54)
a Of the 35 strains, only 3 exhibited the stacked-brick pattern on HEp-2 cells.
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(P 0.05), indicating that positive selection for adaptive structural
changes in agg5A seems to occur rather than purifying selection.
The AAF/V gene cluster promotes EAEC-specific pheno-
types. Alignment of the Agg5A from strains C338-14 and 226
revealed variations on both nucleotide and protein levels (Fig. 2).
Therefore, to assess the phenotypic characteristics of the two
AAF/V variants, we cloned the gene cluster from both strains,
C338-14(pDKAAF5) and 226(pUKAAF5), into a nonfimbriated
FIG 1 (A) Annotation of the AAF/III and AAF/V biogenesis clusters as determined by nucleotide sequence analysis of the product amplified from strains 55989 and
C338-14. Gene designations are from GenBank accession numbers YP002415688 and KP202151. All ORFs encoding 	50 predicted amino acids are indicated. (B)
Sequence alignment of the two adhesins encoded by agg3A and agg5A. Gaps, indicated by dashes, have been inserted to optimize the alignment. Asterisks and points
represent identical and similar residues, identified with the Needle program. The predicted signal peptide is underlined, and the translational start site is indicated by
1.
FIG 2 Sequence alignment of the five Agg5A variants with their differences. Gaps, indicated by dashes, have been inserted to optimize the alignment. Asterisks
and points represent identical and similar residues, identified with the MAFFT (Multiple Alignment using Fast Fourier Transform) program, and these have been
highlighted with colors according to the RasMol amino acid color scheme. Numbers correspond to amino acid positions in the protein encoded by agg5A. The
predicted signal sequence is underlined, and the predicted translation site is indicated by
1.
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laboratoryE. coli strain HB101 generating HB101(pDKAAF5) and
HB101(pUKAAF5). Furthermore, the AAF/III cluster from the
prototype strain 55989(pAAF/3) was also included to compare the
phenotypic properties of the two AAF types.
The AAF/V gene clusters from both strains displayed the typi-
cal stacked-brick pattern of adherence to HEp-2 cells, as well as
biofilm formation on abiotic surfaces (Fig. 3, top). In comparison,
the AAF/III-encoding clone showed significantly less biofilm for-
mation than both AAF/V-encoding clones (P  0.001), and the
same pattern was also seen for adherence to the HEp-2 cells [P
0.05 for HB101(pDKAAF5) and P 0.01 for HB101(pUKAAF5)]
(Fig. 3).
Agg5DCBA is necessary for adherence of EAEC strain C338-
14. To investigate if the AAF/V cluster mediates the aggregative
phenotype and biofilm formation in C338-14, aagg5DCBA mu-
tant of C338-14 was constructed. As expected, deletion of the
AAF/V cluster resulted in the significant loss of the AA phenotype
to HEp-2 cells (P 0.01) as well as biofilm formation (P 0.001).
However, the biofilm formation (Fig. 4, top) and adherence to
HEp-2 cells (Fig. 4, bottom) of the C338-14 agg5DCBA mutant
strain was restored by complementation with plasmid pDKAAF5
encoding its native AAF/V cluster, verifying that AAF/V does con-
fer the aggregative adherence pattern of C338-14.
Interestingly, when we compared the adherent phenotype in
the complemented mutant C338-14agg5ABCD with the two AAF/
V-encoding plasmids (pDKAAF5 and pUKAAF5), the 226 variant
produced significantly (P 0.001) more biofilm than the variant
from C338-14 (Fig. 4, top).
FIG 3 AAF/V-encoding plasmids adhere significantly better than AAF/III.
(Top) The AAF/III-encoding plasmid pAAF/3 promotes biofilm in laboratory
E. coli strain HB101. The two AAF/V variants (pDKAAF5 and pUKAAF5)
produce significantly more biofilm than the AAF/III-encoding plasmid. The
results are represented as the means standard errors of the means for eight
replicates and represent one of three independent experiments performed with
similar results. ***, P  0.001; **, P  0.01; *, P  0.5. (Bottom) HEp-2
monolayer cells were infected with HB101 harboring one of the three fimbria-
encoding plasmids pDKAAF5, pUKAAF5, and pAAF/3. The number of cell-
adhering bacteria was determined 3 h later. The results are presented as the
means standard errors of the means for at least triplicate samples and rep-
resent one of three independent experiments performed with similar results.
***, P 0.001; **, P 0.01; *, P 0.5.
FIG 4 Deletion of the AAF/V cluster attenuates biofilm as well as adhesion to
epithelial cells. (Top) C338-14 forms AAF/V-dependent biofilm in microtiter
plates. Wild-type (WT) C338-14, the AAF/V mutant, and the strains comple-
mented with pDKAAF5 and pUKAAF5 were grown at 37°C in microtiter plates
containing DMEM with 0.45% glucose for 24 h under shaking conditions,
after which biofilm formation was quantified as described in Materials and
Methods. The results are represented as the means  standard errors of the
means for eight replicates and represent one of three independent experiments
performed with similar results. ***, P 0.001; **, P 0.01; *, P 0.5. (Bot-
tom) HEp-2 monolayers were infected with WT, the AAF/V mutant, and the
mutant complemented with pDKAAF5 and pUKAAF5. The numbers of cell-
adhering bacteria were determined after 3 h. The results are represented as the
means standard errors of the means for eight replicates and represent one of
three independent experiments performed with similar results. ***, P 0.001;
**, P 0.01; *, P 0.5.
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Phenotypic characterization of AAFV. In order to assess the
ultrastructure of the AAF/V fimbriae, we performed scanning
electron microscopy (SEM) (Fig. 5). Unlike the afimbriated mu-
tant C338-14agg5ABCD (Fig. 5B), SEM of wild-type strain
C338-14 revealed the presence of fimbriae in the form of hair-like
structures (Fig. 5A). The wild-type fimbriated phenotype was re-
stored when complementing C338-14agg5ABCD with its native
fimbriae from pDKAAFV (Fig. 5).
Hemagglutination (HA) has previously been shown to corre-
late with the expression of AAF by several EAEC strains (20).
Therefore, the HA profile was also examined for AAF/V, and we
observed that like other AAF-producing strains (19), wild-type
C338-14 was capable of agglutinating human erythrocytes,
whereas the AAF/V mutant failed to do so (data not shown).
AggR is necessary for the transcription of agg5A. It is charac-
teristic for AAFs that their expression is promoted by the tran-
scriptional activator AggR (40). To confirm that the agg5A gene is
regulated by AggR, we deleted the aggR gene in C338-14. As ex-
pected, the aggR mutant lost both the phenotype of aggregation to
HEp-2 cells and biofilm formation (data not shown). The effect of
AggR on AAF/V expression was also shown at the transcriptional
level, as an RT-PCR analysis revealed that the agg5A gene was
transcribed in the C338-14 wild-type strain, whereas this agg5A
transcription was undetectable in the aggR mutant. The agg5A
gene transcription was restored when complementing C338-
14aggR with a plasmid carrying aggR (Fig. 6).
Prevalence of the agg5A gene. To determine the prevalence of
the agg5A gene among the 118 Danish EAEC strains, we per-
formed PCR on the AAF-negative strains. Since 32 of the 49 strains
exhibited phenotypically a stacked-brick formation, these were
the ones tested. Fourteen strains (44%) of the 32 strains tested
positive for agg5A. Thus, overall, agg5A was found in 12% of the
118 EAEC strains (Table 3). In order to investigate if agg5A was
associated with disease, we tested isolates from a previous EAEC
case-control study from Mali (12). In this study, 33 strains from
controls (52%) and 22 strains from cases (37.3%) were reported
negative for AAF/I-IV. However, we found that 17 strains (9 cases
and 8 controls) of the 71 strains were positive for the agg5A gene,
although overall agg5A was not significantly correlated with dis-
ease among the EAEC Mali strains (P 0.799) (Table 3).
DISCUSSION
EAEC is a common diarrheal pathogen and has been associated
with endemic pediatric diarrhea and implicated in several out-
breaks. Yet, apart from those outbreak-associated strains, identi-
FIG 5 Scanning electron microscopy (SEM) was performed on the following
strains; C338-14, C338-14agg5ABCD, and the complemented mutant C338-
14agg5ABCD(pDKAAF5). Overnight cultures of bacteria were inoculated
1:100 in DMEM-HG and grown with shaking until an OD600 of 0.8 was
reached; then, they were washed, fixed, stained, dehydrated, and examined.
(A) Wild-type C338-14 showing fimbriae present; (B) a fimbrial mutant,
C338-14agg5ABCD; (C) the complemented mutant with its native fimbriae
(pDKAAF5) with visible fimbriae similar to those of the wild-type.
FIG 6 The agg5A gene is under the control of AggR. RT-PCR for the agg5A
transcript was performed. RNA was extracted from EAEC strain C338-14 (lane
1), C338-14aggR (lane 2), and C338-14aggR(pBADaggR) (lane 3) and sub-
jected to reverse transcriptase-PCR and cDNA amplification by PCR for agg5A
(top) or the constitutive housekeeping gene rpoA (bottom).
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fication of true pathogens remains difficult because of the hetero-
geneity among strains. AAFs are believed to play a key role in
EAEC pathogenicity, and since the discovery of AAF/I, three other
AAFs have been identified (20–22). Nevertheless, several EAEC
strains are negative for any known AAF, suggesting a wide diver-
sity of EAEC adhesive structures, which possibly include unchar-
acterized nonfimbrial and fimbrial adhesins.
In the search for potential new AAF fimbriae, we investigated
118 EAEC strains isolated from Danish travelers with an AAF
multiplex PCR. We found that 58% of the strains were positive for
one of the four known AAFs. This is consistent with previous
studies that found AAF in one-half of the strain collections studied
(11, 12). Among the 49 strains (42%) that were negative for a
known AAFs, 39 (80%) of the strains were positive for the usher of
AAF/III, suggesting that the strains harbored a variant of AAF/III.
The 49 AAF-negative strains in our study were tested for their
ability to form the stacked-brick pattern on epithelial cells, and we
found that 17 of the 49 strains were not able to form the stacked-
brick pattern.
PCR assay with E coli clinical isolate C338-14 and BLAST anal-
ysis revealed an uncharacterized gene, agg5A, whose sequence has
been deposited in GenBank (AB571097, AB571098) and which
was mentioned in three recent studies (27, 41, 42). However, as of
this writing no experimental characterization of this gene is avail-
able.
Here, we show that AAF/V is a new adhesin of EAEC that shows
a significantly better adherent phenotype than that of AAF/III,
with which it shares accessory genes. Our data reveal that like the
other four AAFs, AAF/V is required for mediating the aggregative
adherence pattern and promotes biofilm production, and its ex-
pression requires the activity of the AggR activator, which is a
distinct characteristic of AAFs (40). AAF/V was found to be pres-
ent in 12% of clinical isolates from Danish patients with traveler’s
diarrhea, suggesting the importance of the fimbrial type. When
EAEC strains from a case-control study performed in Mali were
tested (12), AAF/V was present in 8 to 9% of strains in both cases
and controls, supporting the endemic situation of EAEC in Africa.
The facts that AAF/V exhibits high binding capacity to HEp-2 cells
and plastic surfaces and that it was present in a recent outbreak
strain causing HUS in Northern Ireland (27) suggest that this
variant can result in a highly pathogenic combination.
Alignment of the different AAF/V variants revealed a remark-
able variability of the adhesin. Furthermore, the high ratio of non-
synonymous to synonymous mutations (dN/dS) indicates that
AAF/V is under positive selection for structural changes. Interest-
ingly, cloning of two AAF/V variants revealed significantly better
biofilm formation in the AAF/V variant from strain 226 than in
the variant from C338-14, showing that the amino acid changes
between the two variants influence biofilm formation. This reveals
that the amino acid changes in Agg5A can markedly influence the
binding function of the adhesin as previously described for the
FimH adhesin of type 1 fimbriae in E. coli and K. pneumoniae as
well as the MrkD adhesin of K. pneumoniae type 3 fimbriae (43–
45). Besides the potential to directly influence pathogenicity by
providing functional changes, mutational changes of surface
structures can play an important role by allowing immune evasion
during chronic or recurrent infections and/or the ability to colo-
nize new niches in the host (46–48).
The observed variability of the Agg5A adhesin presents a for-
midable challenge when it comes to detection of the fimbriae as
well as for vaccine development. Comparison of the major pilin
subunit from a large subset of different strains representing the
other four AAF variants has not yet been performed. However, the
fact that a known AAF is detected in only approximately 50% of
the isolates in epidemiological studies could reflect difficulties in
designing molecular tools able to detect all variants.
To our knowledge, no previous study has described a chimeric
fimbrial variant like that in AAF/V, in which all accessory genes are
maintained and only the adhesin is replaced. The low prevalence
of Agg3A compared to that of Agg5A could be speculated to be
related to the fact that the allelic exchanges of agg3A with agg5A
confer a higher overall fitness, as exemplified by the increased
biofilm formation as shown in the present study. This hypothesis
is supported by the overall low prevalence of Agg3A in our study as
well as previous studies (11, 12).
In this study, we present a fifth variant in the AAF family, which
exhibits the same aggregative phenotype as the four other variants.
This new variant shares the same accessory genes with AAF/III, as
well as its signal peptide, but the two adhesins have less than 25%
amino acid identity.
We show that Agg5A harbors multiple amino acid substitu-
tions in 5 different Agg5A strains, and by cloning and expression
of two Agg5A variants, we show that the amino acid substitutions
result in altered biofilm abilities. We tested for the prevalence of
this new variant and found that 12% of the Danish collection
harbors AAF/V; thus, AAF/V is more prevalent than AAF/II and
AAF/III (9% each). The same frequency of prevalence was also
observed in the study conducted in Mali (12) (Table 3), suggesting
that Agg5A is the second-most-prevalent AAF in Mali (after
AAF/I) of the currently five AAFs described and the third-most-
prevalent AAF in the Danish collection (after AAF/I and AAF/IV).
The identification of a novel prevalent fimbria type in EAEC may
be a step in the further understanding of the pathogenicity of this
important pathogen.
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